Home Cd rom Global Pharmaceutical R&D Directory 2022: Trends in global R&D investment, cost and culture – ResearchAndMarkets.com

Global Pharmaceutical R&D Directory 2022: Trends in global R&D investment, cost and culture – ResearchAndMarkets.com



DUBLIN – (COMMERCIAL THREAD) – The “Global Pharmaceutical R&D Directory 2022” directory has been added to ResearchAndMarkets.com offer.

The Global Pharmaceutical R&D Directory provides a wealth of key business data on pharmaceutical research trends. At a time when R&D investments are at their highest level, this publication is intended as a strategic reference guide on the major trends in pharmaceutical R&D, as well as the means to compare the performance of your company.

From a review of global R&D investment and productivity to an analysis of R&D trends in each major therapeutic class, the R&D Yearbook provides a comprehensive review of the current R&D environment. .

The R&D directory provides commercial information to save time on:

  • The development pipeline of large companies analyzed by categories and therapeutic stages

  • Compounds in research by therapeutic class for large companies

  • Number of compounds authorized by therapeutic class and stage of development

  • Comparison of Licensed / Company Originating Product Pipelines

  • Average development time to market and attrition data

  • Trends in global R&D investment, costs and culture

  • Number of biotechnological products by phase of development, therapeutic class and type

Main characteristics:

  • Licensing trends for large pharmaceutical companies

  • R&D focus for key therapeutic areas

  • Baseline development time by phase and success for over dozens of therapeutic categories

  • Research compound comparisons by stage of development for dozens of therapeutic areas

  • Analysis of the pipeline development of the previous year by step for all the major pharmaceutical companies in the world


  • Sections 1 and 2 of The R&D Directory examine trends in R&D spending in major markets, changes in employment patterns, and levels of productivity relative to sales of pharmaceuticals.

  • Section 3 reviews the outsourcing industry and examines its role in pharmaceutical R&D.

  • Sections 4 to 9 analyze R&D trends by examining the therapeutic orientation of selected companies, preclinical compounds, biotechnology compounds, compounds in clinical development for each major therapeutic class and licensing activities.

  • Section 10 provides detailed data on attrition and development time for the major therapeutic categories.


  • Western and Eastern Europe incl. UK

  • United States and Canada

  • South and Central America

  • Middle East

  • All Africa

  • All of Asia, including China, India and Japan

  • Australia and New Zealand

Based on primary research, the 2-volume R&D Directory provides the most comprehensive assessment of R&D available! Filled with facts, personalities, charts and statistics, it comes in book form and also as a fully searchable PDF edition and CD-ROM.

For more information on this directory, visit https://www.researchandmarkets.com/r/h5md6x

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for market research reports and international market data. We provide you with the latest data on international and regional markets, key industries, major companies, new products and the latest trends.